CYSLTR1
MOLECULAR TARGETcysteinyl leukotriene receptor 1
CYSLTR1 (cysteinyl leukotriene receptor 1) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CYSLTR1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | diethylstilbestrol | 4.06 | 57 |
| 2 | zafirlukast | 3.89 | 48 |
| 3 | pranlukast | 3.30 | 26 |
| 4 | fpl 55712 | 3.18 | 23 |
| 5 | pptn | 2.89 | 17 |
| 6 | Leukotriene E4 | 2.08 | 7 |
| 7 | Leukotriene C4 | 1.95 | 6 |
| 8 | Leukotriene D4 | 1.79 | 5 |
| 9 | verlukast | 1.79 | 5 |
| 10 | Uridine Diphosphate | 0.69 | 1 |
About CYSLTR1 as a Drug Target
CYSLTR1 (cysteinyl leukotriene receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented CYSLTR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CYSLTR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.